Compugen to Present at the Molecular Medicine Tri-Conference 2013 in San Francisco
05 Febrero 2013 - 6:00AM
Business Wire
Compugen Ltd. (NASDAQ: CGEN) today announced that the Company
was invited to present at the Molecular Medicine Tri-Conference
2013, at Moscone Convention Center in San Francisco,
California.
Dr. John Hunter, Vice President, Antibody Research &
Development at Compugen, Inc., a wholly owned subsidiary of
Compugen Ltd., will participate in a session entitled Cancer
Biologics: Approaches Changing the Treatment of Cancer. Dr.
Hunter's presentation entitled Predictive Drug Discovery for Novel
Cancer Biologics will take place on Thursday, February 14 at 1:45
pm PST. In his talk, Dr. Hunter will demonstrate how Compugen has
applied its predictive discovery platforms to identify novel immune
checkpoints for targeted antibody immunotherapy in cancer.
Validation data for representative targets will also be
presented.
About Compugen
Compugen is a leading therapeutic product discovery company
focused on therapeutic proteins and monoclonal antibodies to
address important unmet needs in the fields of immunology and
oncology. The Company utilizes a broad and continuously growing
integrated infrastructure of proprietary scientific understandings
and predictive platforms, algorithms, machine learning systems and
other computational biology capabilities for the in
silico (by computer) prediction and selection of product
candidates, which are then advanced in its Pipeline Program. The
Company's business model includes collaborations covering the
further development and commercialization of selected product
candidates from its Pipeline Program and various forms of research
and discovery agreements, in both cases providing Compugen with
potential milestone payments and royalties on product sales or
other forms of revenue sharing. In 2012, Compugen established
operations in California for the development of oncology and
immunology monoclonal antibody therapeutic candidates against
Compugen drug targets. For additional information, please visit
Compugen's corporate website at www.cgen.com.
Compugen (NASDAQ:CGEN)
Gráfica de Acción Histórica
De Sep 2024 a Oct 2024
Compugen (NASDAQ:CGEN)
Gráfica de Acción Histórica
De Oct 2023 a Oct 2024